Related Experiment Video
Updated: Jun 9, 2026

Concomitant Isolation of Primary Astrocytes and Microglia for Protozoa Parasite Infection
Published on: March 18, 2020
Cryptococcus gattii meningoencephalitis in an HIV-negative patient from the Peruvian Andes
Ericson L Gutierrez1, Willi Valqui, Luis Vilchez
1Institute of Clinical Research, National University of San Marcos, Lima, Peru.
Abstract:
We report a case of an immunocompetent Peruvian patient from the Andes with a one-month history of meningoencephalitis. Cryptococcus gattii was identified from a cerebrospinal fluid culture through assimilation of D-proline and D-tryptophan as the single nitrogen source. Initially, the patient received intravenous antifungal therapy with amphotericin B. The patient was discharged 29 days after hospitalization and continued with oral fluconazole treatment for ten weeks. During this period, the patient showed clinical improvement with slight right-side residual weakness. Through this case report, we confirm the existence of this microorganism as an infectious agent in Peru.
Insights
Cryptococcus gattii, a fungal pathogen, caused meningoencephalitis in an immunocompetent Peruvian patient. This case confirms its presence as an infectious agent in Peru, highlighting the need for awareness.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Neuroscience
Background:
- Cryptococcus gattii is an emerging fungal pathogen known to cause cryptococcosis, a serious infection.
- While prevalent in tropical and subtropical regions, its presence in the Andes mountains of Peru is less documented.
- Meningoencephalitis, inflammation of the brain and meninges, can be life-threatening.
Observation:
- An immunocompetent Peruvian patient from the Andes presented with a month-long history of meningoencephalitis.
- Cerebrospinal fluid analysis identified Cryptococcus gattii using its unique nitrogen assimilation profile (D-proline and D-tryptophan).
Findings:
- The patient received initial intravenous amphotericin B followed by oral fluconazole for ten weeks.
- Clinical improvement was observed, with only slight residual right-sided weakness post-treatment.
- This case confirms Cryptococcus gattii as an etiological agent of meningoencephalitis in Peru.
Implications:
- This report expands the known geographical distribution of Cryptococcus gattii infections.
- It underscores the importance of considering this pathogen in immunocompetent individuals presenting with neurological infections in the region.
- Further epidemiological studies are warranted to understand the prevalence and transmission dynamics of C. gattii in Peru.
Related Concept Videos
Cryptococcal Meningitis
Toxoplasmosis
Encephalitis l: Introduction
American Trypanosomiasis
Arboviral Encephalitis
Amebiasis
